- RenaissanceRe’s net premiums written for the first quarter reached $3.44 billion, marking a 7.6% increase compared to the previous year and surpassing the estimated $3.29 billion.
- The company reported an operating loss per share of $1.49, a significant decline from an earnings per share of $12.18 in the same period last year.
- Net investment income rose by 3.7% year-over-year to $405.4 million, although it fell short of the estimated $427.1 million.
- Net premiums earned grew by 11% to $2.72 billion, beating the forecasted $2.52 billion.
- The current analyst recommendations for RenaissanceRe include 7 buy ratings, 5 hold ratings, and 2 sell ratings.
A look at Renaissancere Holdings Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Renaissancere Holdings has a promising long-term outlook. With a strong score of 5 in Growth, the company is well-positioned for future expansion and development. Additionally, Renaissancere Holdings received solid scores in Resilience and Momentum, indicating a robust ability to weather challenges and maintain positive momentum in the market.
Renaissancere Holdings also scored well in Value, obtaining a score of 3, which suggests that the company is reasonably priced relative to its intrinsic value. While the Dividend score was slightly lower at 2, Renaissancere Holdings‘ focus on growth and resilience could potentially outweigh the lower dividend outlook. In summary, Renaissancere Holdings Ltd. is a global player in reinsurance and insurance with strong growth prospects, resilience, and positive market momentum.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
